Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2023 08:33 ET | Source: The Insight Partners

Malaria and Sickle Cell Disease Treatment Market Worth $29.17 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

Pune, India, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Sickle cell disease (SCD) is the most common inherited blood disorder that affects the red blood cells. Treatments for SCD can relieve pain and help...
September 15, 2023 12:48 ET | Source: Purdue Research Foundation

Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa

WEST LAFAYETTE, Ind., Sept. 15, 2023 (GLOBE NEWSWIRE) -- A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open...
September 14, 2023 08:01 ET | Source: Ocean Biomedical, Inc.

Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria, and Fibrosis Programs with Scientific Co-founders Jack A. Elias, MD, and Jonathan Kurtis, MD PhD.

Presentation will be hosted live on Ocean Biomedical’s Youtube Channel at 2:00pm ET Providence, RI, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a next-generation...
August 22, 2023 07:31 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria

60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035 for tafenoquine for prevention of Plasmodium falciparum malaria in naïve individualsTafenoquine...
August 10, 2023 08:01 ET | Source: Ocean Biomedical, Inc.

Ocean Biomedical (NASDAQ: OCEA) Provides Latest Updates on its Broad Programs in Malaria, Fibrosis, and Multiple Cancers

Ocean Biomedical will host a Research and Development Day, Live Q&A with Scientific Co-founders, Dr. Jack A. Elias, MD and Dr. Jonathan Kurtis, MD, PhD on September 14, 2023 Providence, RI,...
August 09, 2023 08:31 ET | Source: Ocean Biomedical, Inc.

Ocean Biomedical (NASDAQ: OCEA) Share Price Target Now Averaging $18.21, Based on Research and Development Progress in Three Promising Programs Generating Novel Treatment Candidates for Cancer, Malaria, and Fibrosis.

Ocean Biomedical will host a Research and Development Day, Live Q&A with Scientific Co-founders, Dr. Jack A. Elias, MD and Dr. Jonathan Kurtis, MD, PhD on September 14, 2023 Providence, RI, Aug. ...
July 26, 2023 05:33 ET | Source: Research and Markets

Global Malaria Diagnostics - Strategic Business Report (2023 to 2030): China's Malaria Diagnostics Market on the Rise, Poised for Significant Growth

Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Malaria Diagnostics...
June 22, 2023 05:58 ET | Source: Research and Markets

Malaria Diagnostics Global Market to 2030: Increasing Demand for Diagnostic Tools in Malaria-endemic Countries Drives Growth

Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market Size, Share & Trends Analysis Report 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The global...
May 31, 2023 09:30 ET | Source: Taglich Brothers Inc

Taglich Brothers Initiates Coverage of Ocean Biomedical, Inc.

NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of Ocean Biomedical, Inc. (NASDAQ: OCEA). Ocean Biomedical, Inc. headquartered in...
March 08, 2023 13:34 ET | Source: FFF Enterprises.com

FFF Enterprises Inc. and RightNow Inventory™ Become Vital Members of the Artesunate for Injection Distribution Network

Temecula, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, today announced that it has partnered with Amivas (US), LLC to stock...